NATCO PHARMA

L24230TG1981PLC003201 · ISIN — · 2 filings, FY 2022-23 to FY 2023-24 · standalone basis

Reclaimed at end of life

Tonnes as filed. Totals combine re-used, recycled and safely disposed, because filers place comparable activity in different columns.

CategoryFY 2022-23FY 2023-24
Plastics including packaging not filed142
E-waste not filed0
Hazardous waste not filed0
Other waste not filednot filed
Total reclaimed 0142

NIC codes filed

Products and services accounting for 90 percent of turnover, latest filing.

CodeDescription as filedShare of turnover
210 Manufacture of pharmaceuticals, medicinal chemicals including Active Pharmaceutical Ingredients (API) and Finished Dosage Formulations 90.00%

Source filings

YearBasisTaxonomyTurnover as filed
FY 2022-23 Standalone 2023-06-30 2,35,10,00,000
FY 2023-24 Standalone 2024-04-30 35,68,91,49,431

Figures read from BRSR XBRL as filed. Nothing estimated or restated. How this works · Report an error